Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repetitive Transcranial Magnetic Stimulation for Depression After Basal Ganglia Ischemic Stroke: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial

NCT03159351 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT03159351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03159351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repetitive Transcranial Magnetic Stimulation for Depression After Basal Ganglia Ischemic Stroke: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Zhujiang Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 20, 2017
Completion date
May 31, 2020
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-stroke depression